Global Molecular Diagnostics Infectious Disease Testing Market Research Report 2026(Status and Outlook)
Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.Molecular diagnostics is a technology that diagnoses diseases by detecting and analyzing biomarkers (such as DNA, RNA, proteins, etc.). In infectious disease testing, molecular diagnostics can be used to detect the nucleic acid sequences of pathogens to determine whether infection is viral or bacterial. Traditional infectious disease detection methods usually require tedious culture and detection steps, while molecular diagnostics can extract nucleic acids directly from samples and perform rapid and accurate detection. This method has the advantages of high sensitivity, high specificity and rapid response, which can detect the disease at an early stage, avoid the spread of the disease, and better control the outbreak of infectious diseases. At present, molecular diagnosis has been widely used in the detection of various infectious diseases, such as AIDS, hepatitis, tuberculosis, influenza, new coronavirus, etc., providing important support and help for the prevention and control of infectious diseases.
The global Molecular Diagnostics Infectious Disease Testing market size was estimated at USD 5855.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Molecular Diagnostics Infectious Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Molecular Diagnostics Infectious Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Diagnostics Infectious Disease Testing market.
Global Molecular Diagnostics Infectious Disease Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
BD
bioM?rieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Market Segmentation (by Type)
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Market Segmentation (by Application)
Hospital
Laboratory Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Diagnostics Infectious Disease Testing Market
Overview of the regional outlook of the Molecular Diagnostics Infectious Disease Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Diagnostics Infectious Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Molecular Diagnostics Infectious Disease Testing market size was estimated at USD 5855.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Molecular Diagnostics Infectious Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Molecular Diagnostics Infectious Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Molecular Diagnostics Infectious Disease Testing market.
Global Molecular Diagnostics Infectious Disease Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott Laboratories
BD
bioM?rieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
Market Segmentation (by Type)
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Market Segmentation (by Application)
Hospital
Laboratory Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Molecular Diagnostics Infectious Disease Testing Market
Overview of the regional outlook of the Molecular Diagnostics Infectious Disease Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Diagnostics Infectious Disease Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Molecular Diagnostics Infectious Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Molecular Diagnostics Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Molecular Diagnostics Infectious Disease Testing Segment by Type
1.2.2 Molecular Diagnostics Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Molecular Diagnostics Infectious Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Molecular Diagnostics Infectious Disease Testing Product Life Cycle
3.3 Global Molecular Diagnostics Infectious Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Diagnostics Infectious Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Diagnostics Infectious Disease Testing Market Competitive Situation and Trends
3.8.1 Molecular Diagnostics Infectious Disease Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Molecular Diagnostics Infectious Disease Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Molecular Diagnostics Infectious Disease Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Molecular Diagnostics Infectious Disease Testing Market
5.7 ESG Ratings of Leading Companies
6 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2020-2025)
6.4 Global Molecular Diagnostics Infectious Disease Testing Price by Type (2020-2025)
7 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics Infectious Disease Testing Market Sales by Application (2020-2025)
7.3 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
8 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SALES BY REGION
8.1 Global Molecular Diagnostics Infectious Disease Testing Sales by Region
8.1.1 Global Molecular Diagnostics Infectious Disease Testing Sales by Region
8.1.2 Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region
8.2 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.3 North America
8.3.1 North America Molecular Diagnostics Infectious Disease Testing Sales by Country
8.3.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Molecular Diagnostics Infectious Disease Testing Sales by Country
8.4.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales by Region
8.5.2 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Molecular Diagnostics Infectious Disease Testing Sales by Country
8.6.2 South America Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales by Region
8.7.2 Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Molecular Diagnostics Infectious Disease Testing by Region(2020-2025)
9.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Diagnostics Infectious Disease Testing Production
9.4.1 North America Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.4.2 North America Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Diagnostics Infectious Disease Testing Production
9.5.1 Europe Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.5.2 Europe Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Diagnostics Infectious Disease Testing Production (2020-2025)
9.6.1 Japan Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.6.2 Japan Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Diagnostics Infectious Disease Testing Production (2020-2025)
9.7.1 China Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.7.2 China Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Overview
10.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 BD
10.2.1 BD Basic Information
10.2.2 BD Molecular Diagnostics Infectious Disease Testing Product Overview
10.2.3 BD Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.2.4 BD Business Overview
10.2.5 BD SWOT Analysis
10.2.6 BD Recent Developments
10.3 bioM?rieux
10.3.1 bioM?rieux Basic Information
10.3.2 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Overview
10.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.3.4 bioM?rieux Business Overview
10.3.5 bioM?rieux SWOT Analysis
10.3.6 bioM?rieux Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Basic Information
10.4.2 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Overview
10.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.4.4 Thermo Fisher Scientific Business Overview
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Overview
10.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Siemens AG
10.6.1 Siemens AG Basic Information
10.6.2 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Overview
10.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.6.4 Siemens AG Business Overview
10.6.5 Siemens AG Recent Developments
10.7 Veridex
10.7.1 Veridex Basic Information
10.7.2 Veridex Molecular Diagnostics Infectious Disease Testing Product Overview
10.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.7.4 Veridex Business Overview
10.7.5 Veridex Recent Developments
10.8 Luminex
10.8.1 Luminex Basic Information
10.8.2 Luminex Molecular Diagnostics Infectious Disease Testing Product Overview
10.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.8.4 Luminex Business Overview
10.8.5 Luminex Recent Developments
10.9 GenMark Diagnostics
10.9.1 GenMark Diagnostics Basic Information
10.9.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.9.4 GenMark Diagnostics Business Overview
10.9.5 GenMark Diagnostics Recent Developments
10.10 Qiagen NV
10.10.1 Qiagen NV Basic Information
10.10.2 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Overview
10.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.10.4 Qiagen NV Business Overview
10.10.5 Qiagen NV Recent Developments
10.11 Genomix Biotech
10.11.1 Genomix Biotech Basic Information
10.11.2 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Overview
10.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.11.4 Genomix Biotech Business Overview
10.11.5 Genomix Biotech Recent Developments
10.12 BioTheranostics
10.12.1 BioTheranostics Basic Information
10.12.2 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.12.4 BioTheranostics Business Overview
10.12.5 BioTheranostics Recent Developments
10.13 GenMark Diagnostics
10.13.1 GenMark Diagnostics Basic Information
10.13.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.13.4 GenMark Diagnostics Business Overview
10.13.5 GenMark Diagnostics Recent Developments
11 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
11.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast
11.2 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region
11.2.4 South America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Molecular Diagnostics Infectious Disease Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Molecular Diagnostics Infectious Disease Testing by Type (2026-2035)
12.1.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Molecular Diagnostics Infectious Disease Testing by Type (2026-2035)
12.2 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Application (2026-2035)
12.2.1 Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) Forecast by Application
12.2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Molecular Diagnostics Infectious Disease Testing
1.2 Key Market Segments
1.2.1 Molecular Diagnostics Infectious Disease Testing Segment by Type
1.2.2 Molecular Diagnostics Infectious Disease Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Molecular Diagnostics Infectious Disease Testing Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Molecular Diagnostics Infectious Disease Testing Product Life Cycle
3.3 Global Molecular Diagnostics Infectious Disease Testing Sales by Manufacturers (2020-2025)
3.4 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Diagnostics Infectious Disease Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Molecular Diagnostics Infectious Disease Testing Market Competitive Situation and Trends
3.8.1 Molecular Diagnostics Infectious Disease Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Molecular Diagnostics Infectious Disease Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING INDUSTRY CHAIN ANALYSIS
4.1 Molecular Diagnostics Infectious Disease Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Molecular Diagnostics Infectious Disease Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Molecular Diagnostics Infectious Disease Testing Market
5.7 ESG Ratings of Leading Companies
6 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Type (2020-2025)
6.3 Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (2020-2025)
6.4 Global Molecular Diagnostics Infectious Disease Testing Price by Type (2020-2025)
7 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Molecular Diagnostics Infectious Disease Testing Market Sales by Application (2020-2025)
7.3 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
8 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET SALES BY REGION
8.1 Global Molecular Diagnostics Infectious Disease Testing Sales by Region
8.1.1 Global Molecular Diagnostics Infectious Disease Testing Sales by Region
8.1.2 Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region
8.2 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.3 North America
8.3.1 North America Molecular Diagnostics Infectious Disease Testing Sales by Country
8.3.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Molecular Diagnostics Infectious Disease Testing Sales by Country
8.4.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales by Region
8.5.2 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Molecular Diagnostics Infectious Disease Testing Sales by Country
8.6.2 South America Molecular Diagnostics Infectious Disease Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales by Region
8.7.2 Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET PRODUCTION BY REGION
9.1 Global Production of Molecular Diagnostics Infectious Disease Testing by Region(2020-2025)
9.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Region (2020-2025)
9.3 Global Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Molecular Diagnostics Infectious Disease Testing Production
9.4.1 North America Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.4.2 North America Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Molecular Diagnostics Infectious Disease Testing Production
9.5.1 Europe Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.5.2 Europe Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Molecular Diagnostics Infectious Disease Testing Production (2020-2025)
9.6.1 Japan Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.6.2 Japan Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Molecular Diagnostics Infectious Disease Testing Production (2020-2025)
9.7.1 China Molecular Diagnostics Infectious Disease Testing Production Growth Rate (2020-2025)
9.7.2 China Molecular Diagnostics Infectious Disease Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Basic Information
10.1.2 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Overview
10.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 BD
10.2.1 BD Basic Information
10.2.2 BD Molecular Diagnostics Infectious Disease Testing Product Overview
10.2.3 BD Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.2.4 BD Business Overview
10.2.5 BD SWOT Analysis
10.2.6 BD Recent Developments
10.3 bioM?rieux
10.3.1 bioM?rieux Basic Information
10.3.2 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Overview
10.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.3.4 bioM?rieux Business Overview
10.3.5 bioM?rieux SWOT Analysis
10.3.6 bioM?rieux Recent Developments
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Basic Information
10.4.2 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Overview
10.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.4.4 Thermo Fisher Scientific Business Overview
10.4.5 Thermo Fisher Scientific Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Overview
10.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Siemens AG
10.6.1 Siemens AG Basic Information
10.6.2 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Overview
10.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.6.4 Siemens AG Business Overview
10.6.5 Siemens AG Recent Developments
10.7 Veridex
10.7.1 Veridex Basic Information
10.7.2 Veridex Molecular Diagnostics Infectious Disease Testing Product Overview
10.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.7.4 Veridex Business Overview
10.7.5 Veridex Recent Developments
10.8 Luminex
10.8.1 Luminex Basic Information
10.8.2 Luminex Molecular Diagnostics Infectious Disease Testing Product Overview
10.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.8.4 Luminex Business Overview
10.8.5 Luminex Recent Developments
10.9 GenMark Diagnostics
10.9.1 GenMark Diagnostics Basic Information
10.9.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.9.4 GenMark Diagnostics Business Overview
10.9.5 GenMark Diagnostics Recent Developments
10.10 Qiagen NV
10.10.1 Qiagen NV Basic Information
10.10.2 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Overview
10.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.10.4 Qiagen NV Business Overview
10.10.5 Qiagen NV Recent Developments
10.11 Genomix Biotech
10.11.1 Genomix Biotech Basic Information
10.11.2 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Overview
10.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.11.4 Genomix Biotech Business Overview
10.11.5 Genomix Biotech Recent Developments
10.12 BioTheranostics
10.12.1 BioTheranostics Basic Information
10.12.2 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.12.4 BioTheranostics Business Overview
10.12.5 BioTheranostics Recent Developments
10.13 GenMark Diagnostics
10.13.1 GenMark Diagnostics Basic Information
10.13.2 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
10.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Market Performance
10.13.4 GenMark Diagnostics Business Overview
10.13.5 GenMark Diagnostics Recent Developments
11 MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE TESTING MARKET FORECAST BY REGION
11.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast
11.2 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country
11.2.3 Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region
11.2.4 South America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Molecular Diagnostics Infectious Disease Testing by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Molecular Diagnostics Infectious Disease Testing by Type (2026-2035)
12.1.2 Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Molecular Diagnostics Infectious Disease Testing by Type (2026-2035)
12.2 Global Molecular Diagnostics Infectious Disease Testing Market Forecast by Application (2026-2035)
12.2.1 Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) Forecast by Application
12.2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (M USD)
Table 4. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application
Table 5. Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2025)
Table 11. Global Market Molecular Diagnostics Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Molecular Diagnostics Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Molecular Diagnostics Infectious Disease Testing Sales by Type (K Units)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (M USD)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type (2020-2025)
Table 32. Global Molecular Diagnostics Infectious Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Application
Table 34. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application
Table 35. Global Molecular Diagnostics Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application (2020-2025)
Table 39. Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025)
Table 44. North America Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Molecular Diagnostics Infectious Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Molecular Diagnostics Infectious Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Overview
Table 64. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. BD Basic Information
Table 69. BD Molecular Diagnostics Infectious Disease Testing Product Overview
Table 70. BD Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BD Business Overview
Table 72. BD SWOT Analysis
Table 73. BD Recent Developments
Table 74. bioM?rieux Basic Information
Table 75. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Overview
Table 76. bioM?rieux Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. bioM?rieux Business Overview
Table 78. bioM?rieux SWOT Analysis
Table 79. bioM?rieux Recent Developments
Table 80. Thermo Fisher Scientific Basic Information
Table 81. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Overview
Table 82. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Overview
Table 87. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Siemens AG Basic Information
Table 91. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Overview
Table 92. Siemens AG Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Siemens AG Business Overview
Table 94. Siemens AG Recent Developments
Table 95. Veridex Basic Information
Table 96. Veridex Molecular Diagnostics Infectious Disease Testing Product Overview
Table 97. Veridex Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Veridex Business Overview
Table 99. Veridex Recent Developments
Table 100. Luminex Basic Information
Table 101. Luminex Molecular Diagnostics Infectious Disease Testing Product Overview
Table 102. Luminex Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Luminex Business Overview
Table 104. Luminex Recent Developments
Table 105. GenMark Diagnostics Basic Information
Table 106. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 107. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GenMark Diagnostics Business Overview
Table 109. GenMark Diagnostics Recent Developments
Table 110. Qiagen NV Basic Information
Table 111. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Overview
Table 112. Qiagen NV Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Qiagen NV Business Overview
Table 114. Qiagen NV Recent Developments
Table 115. Genomix Biotech Basic Information
Table 116. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Overview
Table 117. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Genomix Biotech Business Overview
Table 119. Genomix Biotech Recent Developments
Table 120. BioTheranostics Basic Information
Table 121. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 122. BioTheranostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. BioTheranostics Business Overview
Table 124. BioTheranostics Recent Developments
Table 125. GenMark Diagnostics Basic Information
Table 126. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 127. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. GenMark Diagnostics Business Overview
Table 129. GenMark Diagnostics Recent Developments
Table 130. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Molecular Diagnostics Infectious Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (M USD)
Table 4. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application
Table 5. Molecular Diagnostics Infectious Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Diagnostics Infectious Disease Testing Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Infectious Disease Testing as of 2025)
Table 11. Global Market Molecular Diagnostics Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Molecular Diagnostics Infectious Disease Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Diagnostics Infectious Disease Testing Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Molecular Diagnostics Infectious Disease Testing Sales by Type (K Units)
Table 27. Global Molecular Diagnostics Infectious Disease Testing Market Size by Type (M USD)
Table 28. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Type (2020-2025)
Table 29. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Type (2020-2025)
Table 30. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) by Type (2020-2025)
Table 31. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type (2020-2025)
Table 32. Global Molecular Diagnostics Infectious Disease Testing Price (USD/Unit) by Type (2020-2025)
Table 33. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) by Application
Table 34. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application
Table 35. Global Molecular Diagnostics Infectious Disease Testing Sales by Application (2020-2025) & (K Units)
Table 36. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application (2020-2025)
Table 37. Global Molecular Diagnostics Infectious Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 38. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application (2020-2025)
Table 39. Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Table 40. Global Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 41. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region (2020-2025)
Table 42. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 43. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025)
Table 44. North America Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 45. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 47. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 50. South America Molecular Diagnostics Infectious Disease Testing Sales by Country (2020-2025) & (K Units)
Table 51. South America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 54. Global Molecular Diagnostics Infectious Disease Testing Production (K Units) by Region(2020-2025)
Table 55. Global Molecular Diagnostics Infectious Disease Testing Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Region (2020-2025)
Table 57. Global Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Molecular Diagnostics Infectious Disease Testing Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Abbott Laboratories Basic Information
Table 63. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Product Overview
Table 64. Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories SWOT Analysis
Table 67. Abbott Laboratories Recent Developments
Table 68. BD Basic Information
Table 69. BD Molecular Diagnostics Infectious Disease Testing Product Overview
Table 70. BD Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. BD Business Overview
Table 72. BD SWOT Analysis
Table 73. BD Recent Developments
Table 74. bioM?rieux Basic Information
Table 75. bioM?rieux Molecular Diagnostics Infectious Disease Testing Product Overview
Table 76. bioM?rieux Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. bioM?rieux Business Overview
Table 78. bioM?rieux SWOT Analysis
Table 79. bioM?rieux Recent Developments
Table 80. Thermo Fisher Scientific Basic Information
Table 81. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Product Overview
Table 82. Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Recent Developments
Table 85. F. Hoffmann-La Roche Basic Information
Table 86. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Product Overview
Table 87. F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Recent Developments
Table 90. Siemens AG Basic Information
Table 91. Siemens AG Molecular Diagnostics Infectious Disease Testing Product Overview
Table 92. Siemens AG Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Siemens AG Business Overview
Table 94. Siemens AG Recent Developments
Table 95. Veridex Basic Information
Table 96. Veridex Molecular Diagnostics Infectious Disease Testing Product Overview
Table 97. Veridex Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Veridex Business Overview
Table 99. Veridex Recent Developments
Table 100. Luminex Basic Information
Table 101. Luminex Molecular Diagnostics Infectious Disease Testing Product Overview
Table 102. Luminex Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Luminex Business Overview
Table 104. Luminex Recent Developments
Table 105. GenMark Diagnostics Basic Information
Table 106. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 107. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GenMark Diagnostics Business Overview
Table 109. GenMark Diagnostics Recent Developments
Table 110. Qiagen NV Basic Information
Table 111. Qiagen NV Molecular Diagnostics Infectious Disease Testing Product Overview
Table 112. Qiagen NV Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Qiagen NV Business Overview
Table 114. Qiagen NV Recent Developments
Table 115. Genomix Biotech Basic Information
Table 116. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Product Overview
Table 117. Genomix Biotech Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Genomix Biotech Business Overview
Table 119. Genomix Biotech Recent Developments
Table 120. BioTheranostics Basic Information
Table 121. BioTheranostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 122. BioTheranostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. BioTheranostics Business Overview
Table 124. BioTheranostics Recent Developments
Table 125. GenMark Diagnostics Basic Information
Table 126. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Product Overview
Table 127. GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. GenMark Diagnostics Business Overview
Table 129. GenMark Diagnostics Recent Developments
Table 130. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Molecular Diagnostics Infectious Disease Testing Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Molecular Diagnostics Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Product Life Cycle
Figure 13. Molecular Diagnostics Infectious Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Molecular Diagnostics Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Molecular Diagnostics Infectious Disease Testing
Figure 19. Global Molecular Diagnostics Infectious Disease Testing Market PEST Analysis
Figure 20. Global Molecular Diagnostics Infectious Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type
Figure 27. Sales Market Share of Molecular Diagnostics Infectious Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Diagnostics Infectious Disease Testing by Type in 2025
Figure 29. Market Share of Molecular Diagnostics Infectious Disease Testing by Type (2020-2025)
Figure 30. Market Share of Molecular Diagnostics Infectious Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application
Figure 33. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application in 2025
Figure 37. Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 45. U.S. Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Diagnostics Infectious Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Diagnostics Infectious Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Diagnostics Infectious Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Diagnostics Infectious Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 55. Germany Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region in 2024
Figure 68. China Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 82. Brazil Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Diagnostics Infectious Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Molecular Diagnostics Infectious Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Molecular Diagnostics Infectious Disease Testing Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Molecular Diagnostics Infectious Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Molecular Diagnostics Infectious Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Global Molecular Diagnostics Infectious Disease Testing Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Diagnostics Infectious Disease Testing Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Diagnostics Infectious Disease Testing Product Life Cycle
Figure 13. Molecular Diagnostics Infectious Disease Testing Sales Share by Manufacturers in 2025
Figure 14. Global Molecular Diagnostics Infectious Disease Testing Revenue Share by Manufacturers in 2025
Figure 15. Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Molecular Diagnostics Infectious Disease Testing Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Diagnostics Infectious Disease Testing Revenue in 2025
Figure 18. Industry Chain Map of Molecular Diagnostics Infectious Disease Testing
Figure 19. Global Molecular Diagnostics Infectious Disease Testing Market PEST Analysis
Figure 20. Global Molecular Diagnostics Infectious Disease Testing Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Molecular Diagnostics Infectious Disease Testing Market Share by Type
Figure 27. Sales Market Share of Molecular Diagnostics Infectious Disease Testing by Type (2020-2025)
Figure 28. Sales Market Share of Molecular Diagnostics Infectious Disease Testing by Type in 2025
Figure 29. Market Share of Molecular Diagnostics Infectious Disease Testing by Type (2020-2025)
Figure 30. Market Share of Molecular Diagnostics Infectious Disease Testing by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application
Figure 33. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application (2020-2025)
Figure 34. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Application in 2025
Figure 35. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application (2020-2025)
Figure 36. Global Molecular Diagnostics Infectious Disease Testing Market Share by Application in 2025
Figure 37. Global Molecular Diagnostics Infectious Disease Testing Sales Growth Rate by Application (2020-2025)
Figure 38. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region (2020-2025)
Figure 39. Global Molecular Diagnostics Infectious Disease Testing Market Size by Region (2020-2025)
Figure 40. North America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 43. North America Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 45. U.S. Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Molecular Diagnostics Infectious Disease Testing Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Molecular Diagnostics Infectious Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Molecular Diagnostics Infectious Disease Testing Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Molecular Diagnostics Infectious Disease Testing Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 53. Europe Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 55. Germany Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region in 2024
Figure 67. Asia Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region in 2024
Figure 68. China Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 79. South America Molecular Diagnostics Infectious Disease Testing Sales Market Share by Country in 2024
Figure 80. South America Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 81. South America Molecular Diagnostics Infectious Disease Testing Market Size by Country in 2024
Figure 82. Brazil Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Molecular Diagnostics Infectious Disease Testing Market Size by Region in 2024
Figure 92. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Molecular Diagnostics Infectious Disease Testing Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Molecular Diagnostics Infectious Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Molecular Diagnostics Infectious Disease Testing Production Market Share by Region (2020-2025)
Figure 103. North America Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 106. China Molecular Diagnostics Infectious Disease Testing Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Molecular Diagnostics Infectious Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Molecular Diagnostics Infectious Disease Testing Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Molecular Diagnostics Infectious Disease Testing Market Share Forecast by Type (2026-2035)
Figure 111. Global Molecular Diagnostics Infectious Disease Testing Sales Forecast by Application (2026-2035)
Figure 112. Global Molecular Diagnostics Infectious Disease Testing Market Share Forecast by Application (2026-2035)
